(Press-News.org) GALVESTON, Texas — An international research team has determined the DNA sequence of the mosquito species whose bite transmits West Nile virus, St. Louis encephalitis virus and the microscopic worm responsible for elephantiasis.
University of Texas Medical Branch at Galveston researchers played a vital part in the push to sequence the genome of Culex quinquefasciatus, applying expertise gained through more than a decade of studying the mosquito species and the viruses it spreads. The UTMB scientists collaborated with researchers at 38 other institutions on the project, including the University of California, Riverside, the European Bioinformatics Institute, Boston College and the Harvard School of Public Health.
"Culex pipiens quinquefasciatus is the most widely distributed mosquito in the world, and in terms of disease transmission to humans it's one of the three most important mosquito species," said UTMB professor Stephen Higgs, one of the authors of two papers related to the project that will appear in the Oct. 1 issue of Science. "This work gives us a terrific platform to improve our understanding of the dynamics of infection, which has to be done if we're going to find ways to interrupt disease transmission."
The other two mosquito species identified by Higgs as part of the "triad of the most important disease vectors" are Anopheles gambiae (which transmits malaria) and Aedes aegypti (yellow fever virus and dengue virus). The genome of Anopheles gambiae was published in 2002, and that of Aedes aegypti in 2007.
"This is really exciting for us, because we can finally perform experiments that we've wanted to do for seven or eight years," said UTMB assistant professor Dana Vanlandingham, also an author of the Science papers. "Our basic question is why do certain mosquito species transmit a particular virus and other mosquito species do not? Why don't they all carry all the viruses? We don't know, but now we have three different systems for comparative studies to investigate interactions between viruses and mosquitoes."
In the first of the Science papers ("Sequencing of Culex quinquefasciatus Establishes a Platform for Mosquito Comparative Genomics"), researchers announce that they have identified all of Culex quinquefasciatus' 18,883 genes. Each gene can produce one of the proteins that make up the mosquito and determine its behavior — including the way its immune system responds to infection by viruses, bacteria and parasites.
The second paper ("Pathogenomics of Culex quinquefasciatus and Meta-Analysis of Infection Responses to Diverse Pathogens") focuses specifically on that immune response. UTMB's biosafety level 3 laboratories contributed significantly to its data on West Nile virus by allowing researchers to safely infect Culex mosquitoes with West Nile virus and then extract genetic material that provided information on the mosquitoes' response to the virus.
"Culex quinquefasciatus is the main vector for West Nile — it's common here along the Gulf Coast of Texas, but closely related species are found all over the country, and it bites both birds and humans," Higgs said. "There have been about a million human infections with West Nile in the United States and, presumably, hundreds of millions of bird infections. Almost every one of those infections was started by a mosquito bite." This year 24 human cases have been reported in Texas, with two deaths.
Higgs, Vanlandingham and their UTMB colleagues have been working on the relationship between Culex quinquefasciatus and West Nile ever since the virus first arrived in North America in 1999. "For years we've been looking at the interaction of viruses and mosquito gene expression in other mosquito species infected with various viruses, because those were the only systems that were available," Vanlandingham said. "We've been able to see some parts of the Culex West Nile virus picture, but we haven't had the appropriate tools for detailed genetic studies. This work will provide the base for a lot of people to investigate mosquito-borne pathogens, from multiple angles."
###
The National Institutes of Health and the National Institute of Allergy and Infectious Diseases provided funding for this research.
ABOUT UTMB: Established in 1891, Texas' first academic health center comprises four health sciences schools, three institutes for advanced study, a research enterprise that includes one of only two national laboratories dedicated to the safe study of infectious threats to human health, and a health system offering a full range of primary and specialized medical services throughout Galveston County and the Texas Gulf Coast region. UTMB is a component of the University of Texas System.
END
PHOENIX, Ariz. — Sept. 30, 2010 — DNA methylation — a modification of DNA linked to gene regulation — is altered with increasing severity in a blood cancer called multiple myeloma, according to a study by Mayo Clinic and the Translational Genomics Research Institute (TGen).
And at specific points of DNA, "global hypomethylation," in which many genes lose the modification, may be associated with the step-by-step development of myeloma, according to a scientific paper published this month in the journal Cancer Research.
"This is the first study to show that hypomethylation ...
Italian researchers report that liver transplant candidates who have a strong religious connection have better post-transplant survival. This study also finds that religiosity—regardless of cause of death—prolongs the life span of individuals who underwent liver transplantation. Full findings are now available online and in the October issue of Liver Transplantation. a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
Much of the medical profession today is focused on the delivery of services, rather than ...
An Australian study of identical twins shows that a rare genetic form of epilepsy can be caused by a genetic mutation that occurs in the embryo, and not necessarily passed down from parents.
The study was led by the University of Melbourne and Austin Health and published in the New England Journal of Medicine.
Professor Berkovic, Director of the Comprehensive Epilepsy Program at Austin Health and Epilepsy Research Centre at the University of Melbourne and lead investigator on the study said this is an exciting finding revealing how a mutation in the embryo can cause ...
Philadelphia, PA, 30 September, 2010 - There is growing evidence that two neurotransmitters - dopamine and glutamate - are abnormal in people with psychotic illness, including schizophrenia. Among many other things, these chemicals play a role in cognitive functions, such as memory, learning, and problem-solving.
A new study in Biological Psychiatry is now the first to examine the relationship between these two brain chemicals by measuring both in the same individuals.
Dr. James Stone and colleagues studied people with sub-threshold psychotic symptoms, who were at ...
New research has linked psychosis with an abnormal relationship between two signalling chemicals in the brain. The findings, published in tomorrow's edition of the journal Biological Psychiatry, suggest a new approach to preventing psychotic symptoms, which could lead to better drugs for schizophrenia.
Schizophrenia is one of the most common severe mental health conditions. Sufferers experience symptoms of psychosis – an inability to distinguish between reality and imagination – such as hallucinations and delusions. The condition tends to begin in the late teens or twenties, ...
If you are one of the millions of Americans with high blood pressure, more help is on the way. That's because a new research study published in the October 2010 print issue of The FASEB Journal (http://www.fasebj.org) shows that a protein, called P450, metabolizes arachidonic acid in our blood vessel walls to create a tiny molecule with a big name—epoxyeicosatrienoic acid (EET)—which in mice, turns off genes responsible for vascular inflammation and ultimately relaxes blood vessels to lower blood pressure. This protein and genes are also present in humans.
"We hope these ...
A new report published in the October 2010 print issue of The FASEB Journal (http://www.fasebj.org) offers a ray of hope in the search for new cancer drugs. By examining the seemingly conflicting roles of how oncogenes and tumor suppressor genes handle cellular stress, scientists from the Institute for Advanced Studies in New Jersey argue that each of these opposing systems could be potent drug targets in the effort to stop cancer. In addition, their hypothesis provides new insights into what contributes to immunological disorders such as chronic inflammation and autoimmune ...
A new research report in the October 2010 print issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) sheds important light on how our immune systems detect invading organisms to be destroyed and removed from our bodies. The information from this research should ultimately help lead to the development of new drugs and treatments that allow health care providers to prevent runaway immune reactions that can have devastating consequences for people.
"Our study helps us to understand exactly how the immune system is activated when it comes across infection ...
An experimental vaccine intended to prevent genital herpes disease in women, although generally safe and well-tolerated, proved ineffective when tested in the recently concluded clinical study known as the Herpevac Trial for Women.
The Phase 3 trial, sponsored by GlaxoSmithKline (GSK) Biologicals, based in Belgium, with support from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, began in 2002. A total of 8,323 women aged 18-30 years participated in the trial at 50 sites in the United States and Canada. At ...
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent. The results of this largest study ever conducted on women in this age group confirm that the use of the age of 50 as a threshold for breast cancer screening is scientifically unfounded. Women should begin getting annual mammograms at age 40.
"This study, which looked at the performance of screening mammography as it is actually used, rather than ...
